31750-45-5 (他莫昔芬杂质D,Ethanamine,2-[4-(1,2-diphenyl-1-propenyl)phenoxy]-N,N-dimethyl-, (E)- (9CI))

枸橼酸他莫昔芬杂质D(EP) 标准品;他莫昔芬杂质D;(E)-2-[4-(1,2-二苯基-1-丙烯基)苯氧基]-N,N-二甲基乙胺;

Ethanamine,2-[4-(1,2-diphenyl-1-propenyl)phenoxy]-N,N-dimethyl-, (E)- (9CI);2-[4-[(E)-1,2-diphenylprop-1-enyl]phenoxy]-N,N-dimethylethanamine;(E)-2-(4-(1,2-Diphenyl-1-propenyl)phenoxy)-N,N-dimethylethanamine;Ethanamine, 2-(4-(1,2-diphenyl-1-propenyl)phenoxy)-N,N-dimethyl-, (E)-;(E)-desethyl methyl tamoxifen;UNII-QSK121C25P;SCHEMBL17164708;31750-45-5;2-(4-((E)-1,2-DIPHENYLPROP-1-ENYL)PHENOXY)-N,N-DIMETHYLETHANAMIN;Q27287477;Desethyl methyl tamoxifen, (E)-;QSK121C25P;Tamoxifen Citrate Imp. D (EP) E-Isomer; Tamoxifen Imp. D (EP) E-Isomer; 2-[4-[(E)-1,2-Diphenylprop-1-enyl]phenoxy]-N,N-dimethylethanamine; Tamoxifen Citrate Impurity D as E-Isomer; Tamoxifen Impurity D as E-Isomer;

YBZBQYHSLRTDHL-LKUDQCMESA-N

1S/C25H27NO/c1-20(21-10-6-4-7-11-21)25(22-12-8-5-9-13-22)23-14-16-24(17-15-23)27-19-18-26(2)3/h4-17H,18-19H2,1-3H3/b25-20+

O(CCN(C)C)C1C=CC(=CC=1)/C(/C1C=CC=CC=1)=C(\C)/C1C=CC=CC=1